Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to determine whether nonsteroidal antiinflammatory drug lornoxicam in combination with low dose aspirin (100mg/day) is effective and safe in patients with Acute Coronary Syndrome without persistent ST-segment elevation.
Epistemonikos ID: 2a25d25845d11cdbb4b1eb1c004b501cdbefd3fd
First added on: May 05, 2024